Skip to main content
An Agency study engineered a molecule that blocked the growth of prostate cancer and shrank the size of the tumour. This sets the stage for the development of innovative approaches to treat androgen-independent prostate cancer — the advanced stage of the disease for which there is no cure.
Agency researchers were part of an international team that isolated a unique stem cell population from normal adult breast tissue. This was the first time a cell population has been purified from a normal adult organ, other than blood or bone marrow, and then shown to have tissue-specific stem cell activity.
The Agency’s new $95 million, Research Centre, funded partly by BC Cancer Foundation donors, opened in Vancouver. It received Canada’s first LEED Gold designation for a medical facility and has become a symbol and icon for its groundbreaking translational research output.
Researchers published findings in the journal Immunity about the activity of a protein, SHIP, which regulates how we respond to microbial infections and inflammation-inducing agents. This research has implications for cancer control and increases our understanding of allergies and autoimmune disorders such as asthma. It could play an important role in controlling septic shock in hospital patients.
Researchers discovered a gene whose existence may explain the ability of cancer tumours to grow and thrive. The research brings to light new information about the causes of genetic instability and cell death.
The Agency's Genome Sciences Centre, the BC Centre for Disease Control and the Animal Health Centre, Ministry of Agriculture, Food and Fisheries, completed the genome sequencing of the Influenza A virus implicated in B.C.’s avian influenza outbreak.
The Agency's Vancouver Island Centre became the first cancer treatment centre in Western Canada to study a more localized form of radiation therapy for early breast cancer — a technique that can reduce treatment time and improve quality of life for patients.
Researchers at the Agency’s Genome Sciences Centre were the first in the world to sequence the genome of the coronavirus linked to SARS (severe acute respiratory syndrome).
The Trev & Joyce Deeley Research Centre opened in the Agency’s Vancouver Island Centre in Victoria with $6.4 million in funding from BC Cancer Foundation donors.
Agency researchers joined a national team collaborating to examine factors — including the use of cellular phones and other radiofrequency exposures — that may increase the risk of developing tumours of the brain, head, and neck. In 2010, the team announced it found no evidence of increased cancer risk.
Your browser is out-of-date!
For an optimal viewing experience, please update your browser. Update my browser now!